Four kinds of retrovirus protease inhibitors (RPI-856 A, B, C and D) were isolated as white powderfrom the culture filtrate of a soil isolate, Streptomyces sp. AL-322by column chromatography using Diaion HP-20, Sephadex LH-20, ODSreversed phase HPLCand SP-2SW ion exchange HPLC. The structures of these inhibitors were elucidated by physico-chemical properties, A and B, and RPI-856 C and D were both determined to be diastereomers each other on the asymmetric carbon in AOPBA. These four inhibitors strongly inhibited in vitro HIV-1 protease and HTLV-I protease both derived from recombinant Escherichia coli with IC50 of lO~7~10~8 M.
The human immunodeficiency virus (HIV) encodes a protease which proteolytically processes the precursor gag and gag-pol polyprotein to form mature proteins essential for production of infectious viral particles. For this reason, attempts to develop agents that inhibit this protease have been extensively made for the treatment of acquired immunodeficiency syndrome (AIDS) and related diseases1~9).
In the previous paper, we reported purification of enzymatically active HTLV-Iprotease expressed in recombinant Escherichia coli and charactarization of the purified enzyme10). Wealso expressed HIV-1 protease in recombinant E. coli. In the present work wescreened various microbial metabolites in search In this paper, we describe the taxonomy of the producing strain, the purification, the structure and protease inhibitory activities of RPI-856 A, B, C and D.
Materials and Methods

Materi als
Recombinant HIV-1 protease was expressed as a larger precursor in E. coli MM294(DE3)/pHIV7004 and autoprocessed to form a mature molecule. The protease was partially purified on S-Sepharose FF and Sephacryl S-100 HRcolumns as described by Strickler et al.11} . Recombinant HTLV-I protease was expressed and partially purified from E. coli MM294(DE3)/pHTI7707 as described10). 
Taxonomic Studies
The media and procedures used for cultural and physiological characterization of strain AL-322 were those described by Shirling and Gottlieb12) . The color names used in these studies were determined by comparing with the color chips of the "Color Harmony Manual 4th Ed. Container Corporation of America, Chicago, 1958". Utilization of carbon sources were examined by the method of Pridham and Gottlieb13) . The chemical composition of the cell wall was analyzed by the method of Becker et a/.14). Sugars in the whole cells were analyzed by the method of Mikami and Ishida15).
Fermentation
For the production of inhibitors the following media were used: the seed medium consisting of soluble starch 3%, glucose 2%, soy bean flour 1%, corn steep liquor 1%, Polypepton 0.5%, NaCl 0.3% and CaCO30.5%, and the main medium consisting of glucose 0.5%, dextrin 5%, soy bean meal 3.5% and CaCO30.7%. The microorganisms were inoculated to 40ml of the seed medium contained in a 200-ml shake flask and cultivated for 3 days at 28°C on a rotary shaker. Fifteen milliliters of the culture fluid were inoculated to 500ml of the seed medium contained in a 2-liter Sakaguchi flask and the flask was shaken for 3 days at 28°C on a reciprocal shaker at 82rpm. One liter of the resulting culture fluid was inoculated to 120 liters of the main mediumcontained in a 200-liter fermentor and fermentation was carried out at 28°C for 4 days under agitation of 120rpm and aeration of 100%v/v/minute.
Isolation ofRPI-856 A, B, C and D The culture filtrate (100 liters) was passed through a column of Diaion HP-20 (15cm x 60cm). The column was washed first with water and then with 30%MeOH. Active substances were eluted with 90% MeOH. The active fractions were pooled and concentrated. The concentrate was applied onto a Sephadex LH-20 column (6 x 107 cm) and the column was developed with 90% MeOH.After concentration of the active fraction, the concentrate was applied onto an ODS-120Tcolumn equilibrated at pH7.2. The column was developed with a linear gradient of 18~39% CH3CN.Two active fractions, one containing RPI-856 A and B and the other containing RPI-856 C and D, were each desalted on an ODS-120Tcolumn. The VOL.47 NO.5 THE JOURNAL OF ANTIBIOTICS 559 fraction containing RPI-856 A and B was passed through an SP-2SW column at pH 2.5, and the column was developed with a linear gradient of 3~50him Na2SO4. This enabled the separation of RPI-856 A and B. The fraction containing RPI-856 C and D was passed through an SP-2SW column at pH 4.0, and the column was developed with a linear gradient of 8~50 mMNa2SO4. This enabled the separation of RPI-856 C and D. Finally, each pure fraction was desalted on an ODS-120T column to give RPI-856 A, B, C and D each as white powder.
Assay for Enzyme Inhibitory Activity
The assays of inhibition of HIV-1 protease and HTLV-Iprotease were based on hydrolysis of peptide substrates. HIV-1 protease inhibition assay was performed in a total volume of 30 /zl. The reaction mixture consisted of 3fig substrate gag-ll (SQVSQNYPIVQNL) having the gag pl7/p24 cleavage site, 1.0m
NaCl -10% glycerol -0.175 M sodium phosphate buffer (pH 6.5), partially purified HIV-1 protease and a test sample. Incubation was carried out at 37°C for 3 hours. Peptide cleavage was analyzed by HPLCwith a linear gradient of0-55% CH3CNon a reversed phase C-18 column (YMC-Pack, FL-ODS, 4.6 x 30mm) and the areas of the peaks corresponding to the cleavage products (SQVSQNY) and the residual substrate were used to calculate the percentage of cleavage. HTLV-Iprotease inhibitory assay was performed similary with a substrate peptide gag-1 (YVEPTAPQVLPVMHP) as described in the previous paper10). The inhibitory activities toward cathepsin D, pepsin and chymosin were assayed using hemoglobin16) as substrate. The inhibitory activity toward prolyl endopeptidase was assayed using Z-Gly-Pro-pNA17). The inhibitory activity toward other proteases were measured as described in the previous paper18).
Analytical Instruments
UVand IR spectra were recorded on a Hitachi 220A spectrophotometer and a Hitachi 285 infrared spectrophotometer, respectively. Aminoacid analysis was carried out with a Waters PICOTAGamino acid analyzer. SI-MSspectra were measured with a Hitachi M-80Amass spectrometer. NMR spectra were recorded on a Bruker AC-300 instrument (1H, 300 MHz; 13C, 75 MHz). Automatic Edman degradation was carried out with an Applied Biosystems 470Asequencer.
Reduction of RPI-856 A RPI-856 A (37.5mg) was dissolved in 15ml of 50% CH3CN-0.1% TFA and NaBH3CN(150mg) was added, and the mixture was stirred for 90 minutes at 0°C. The reaction mixture was diluted with water and applied onto an ODS-120Tcolumn. Twopeak fractions were pooled, concentrated and freeze-dried to give H-l (9.8mg) and H-2 (23.0mg) each as white powder.
Results and Discussion
Taxonomic Characterization of the Producing Strain The producing organism, strain AL-322, was isolated from a soil sample collected in Otsu City, Shiga Prefecture, Japan. It produced aerial mycelium, monopodially branched from well-developed substrate mycelia, with Rectiflexibiles spore-bearing hyphae. The mature spore chains were generally long with more than 30 spores per chain. The spores were cylindrical (0.6 x 1.7~2.0ium) and their surfaces were smooth. Sporangia, zoospores and sclerotia were not observed. Cultural and physiological characteristics of strain AL-322 are shown in Tables 1 and 2 , respectively. The aerial mycelium was white to ivory tint and melanoid pigment was not formed on either tyrosine agar or peptone -yeast extract iron agar. The hydrolysate of cell walls of strain AL-322 contained both ll-and m&so-diaminopimelic acids. Galactose and mannosewere detected in the whole cells, but arabinose, xylose and madurose were absent. MK-9(H6) and MK-9(H8) as predominant menaquinones were detected in the cell extract. Based on these taxonomic characteristics, strain AL-322 was considered to belong to the genus Streptomyces19'20). Strain AL-322 has been deposited to Institute for Fermentation, Osaka under the accession No. IFO 15088. Characterization of the producer was carried out according to the methods described by Shirling and Gottlieb12). Unless otherwise stated, results after cultivation at 28°C for 14 days are described. RPI-856 A and B thus obtained were interconvertible in alkaline solutions. Whenboth the solutions of RPI-856 A and B (pH 9.0) were allowed to stand for 24 hours at 37°C, they reached an equilibrium state (A : B=4 : 6). The same relationship was also observed between RPI-856 C and D. 17.6 17.5 1 3C NMR spectrum recorded at 75 MHz in DMSO-fl?6. Chemical shifts measured from TMS as internal reference. ADPAA; 2-amino-2-(3,5-dihydroxyphenyl)-acetic acid. AOPBA; 3-amino-2-oxo-4-phenylbutyric acid. Ar; aromatic signal.
Structural
Determination of RPI-856 A, B, C and D The physico-chemical properties of RPI-856 A, B, C and D are summarized in Table 3 . The UV spectra of RPI-856 A, B, C and D showed a strong absorption at 278 nm in water. Their IR spectra showed absorption bands at 1645~1670 and 1515~1520cm"1, suggesting the presence of peptide bonds. The amino acid analysis indicated the presence of valine, leucine and aspartic acid (3 : 1 : 1) in RPI-856 A and B, and valine and leucine (3 : 1) in RPI-856 C and D. Edman degradation of RPI-856 A, B, C and D all gave valine as N-terminus. Carboxypeptidase P digestion of RPI-856 A and B at 37°C for 4 hours liberated 0.8mol aspartic acid and 0.05mol of valine. Digestion of RPI-856 A and B each gave a new peak on SP-2SW ion exchange HPLC. The peak derived from A was identical to RPI-856 C and the peak derived from B was identical to RPI-856 D. Carboxypeptidase P digestion at 37°C for 20 hours of RPI-856 C and D liberated 0.2mol of valine. These results suggested that the C-terminal amino acids of RPI-856 C and D were both valine and that RPI-856 A and B had an additional aspartic acid residue at the C-terminus of RPI-856 C and D, respectively.
The XHNMRand 13C NMRspectra of RPI-856 A, B, C and D are shown in Tables 4 and 5 . *H NMRspectra indicated the presence of the 4 partial structures (I~IV) shown below, in addition to the usual amino acid residues/The COLOC spectrum of RPI-856 A gave information on the linkages of these partial structures and the amino acid sequence (Fig. 2) . The structures I and II were linked to constitute a 2-amino-2-(3,5-dihydroxyphenyl)acetic acid (ADPAA)residue. On the other hand, the structures III and IV were supposed to constitute a 3-amino-2-oxo-4-phenylbutyric acid (AOPBA) residue with the carbonyl group observed at 195.8 ppm. The presence of this residue was confirmed by reduction of the carbonyl group to yield dihydro compounds (H-l and H-2), as shown in Fig. 3 .
Deletion of the C-terminal aspartic acid residue of RPI-856 A resulted in formation of RPI-856 C. RPI-856 B and D were diastereomers of RPI-856 A and C, respectively, at the /?-methine carbon ofAOPBA residue.
Someprotease inhibitors which contain an unusual amino acid residue having an a-ketone group have been reported. Poststatin produced by a Streptomyces sp. inhibits prolyl endopeptidase and contains 3-amino-2-oxo-valeric acid (postin)22). A synthetic inhibitor of cysteine protease and serine protease was reported to contain AOPBA23). An amino peptidase inhibitor, bestatin, which is produced by reduction of the ketone group of AOPBA. It is interesting that the unusual amino acid, AOPBA, and its derivatives are found in the structures of several protease inhibitors as described The dihydro derivatives of RPI-856 A, H-l and H-2, showed very weak inhibitory activity. Therefore, the a-ketone group of AOPBAin RPI-856 seems to have a critical role for the inhibitory activity.
